What Do We Know Today about Long COVID? Nursing Care for a New Clinical Syndrome
1. Long COVID: The Disease That Lasts
2. Symptoms Accompanying Long COVID Syndrome
3. What Measures Should Be Taken with a Long COVID Patient?
- Nutritional assessment, due to the situation of deficiency caused in some cases by acute infection. Weight, height, BMI, and total protein, albumin, ferritin, vitamin B12 and vitamin D should be measured in laboratory tests. Screening can be performed using the MUST tool [18].
- Sarcopenia assessment by loss of muscle mass. Physical tests to measure muscle strength and physical performance, such as the SARC-F scale, are used for this purpose [19].
- Dependency assessment, mainly in elderly or multi-pathological patients, by means of the Barthel scale [20].
- Emotional assessment, due to the psychological impact of the disease. There are countless scales for this, such as the EADG questionnaire [21].
- Social assessment, due to the impairment of social life associated with long COVID. The FSQ scale can be used to determine social participation [22].
4. Nursing Care in Long COVID Patients
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Greenhalgh, T.; Knight, M.; A’Court, C.; Buxton, M.; Husain, L. Management of post-acute COVID-19 in primary care. BMJ 2020, 370, m3026. [Google Scholar] [CrossRef] [PubMed]
- Davis, H.E.; Assaf, G.S.; McCorkell, L.; Wei, H.; Low, R.J.; Re’Em, Y.; Redfield, S.; Austin, J.P.; Akrami, A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine 2021, 38, 101019. [Google Scholar] [CrossRef] [PubMed]
- Patterson, B.K.; Guevara-Coto, J.; Yogendra, R.; Francisco, E.B.; Long, E.; Pise, A.; Rodrigues, H.; Parikh, P.; Mora, J.; Mora-Rodríguez, R.A. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front. Immunol. 2021, 12, 700782. [Google Scholar] [CrossRef]
- Rajan, S.; Khunti, K.; Alwan, N.; Steves, C.; MacDermott, N.; Morsella, A.; Angulo, E.; Winkelmann, J.; Bryndová, L.; Fronteira, I.; et al. In the Wake of the Pandemic Preparing for Long COVID; Health Systems and Policy Analysis; WHO Regional Office for Europe: Copenhagen, Denmark, 2021. [Google Scholar]
- Lopez-Leon, S.; Wegman-Ostrosky, T.; Perelman, C.; Sepulveda, R.; Rebolledo, P.A.; Cuapio, A.; Villapol, S. More than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Sci. Rep. 2021, 11, 16144. [Google Scholar] [CrossRef] [PubMed]
- WHO. The latest on the COVID-19 global situation and long-term sequelae. In What We Know about Long-Term Effects of COVID-19; WHO: Geneva, Switzerland, 2020. [Google Scholar]
- National Institute for Health and Care Excellence. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19; NICE: London, UK, 2020; pp. 1–35. [Google Scholar]
- Ledo, M.D.P.R.; del Olmo, L.A.; Rodríguez, E.R.; Acebo, F.G. Descripción de los 201 síntomas de la afectación multiorgánica producida en los pacientes afectados por la COVID Persistente. Med. Gen. 2021, 10, 60–68. [Google Scholar]
- Rodríguez Ledo, P.; Armenteros del Olmo, L.; Guerrero Caballero, S.; Bilbao Fernández, S. en representación de Sociedad Española de Médicos Generales y de Familia (SEMG) y colectivo Long COVID ACTS. La persistencia de síntomas de la COVID-19 y su diagnóstico en la primera ola de la pandemia en España. Med. Gen. Fam. 2021, 10, 53–59. [Google Scholar] [CrossRef]
- Súarez Reyes, A.; Villegas Valverde, C.A. Características y especialización de la respuesta inmunitaria en la COVID-19. Rev. Fac. Med. 2020, 63, 7–18. [Google Scholar] [CrossRef]
- Lechien, J.R.; Chiesa-Estomba, C.M.; Place, S.; Van Laethem, Y.; Cabaraux, P.; Mat, Q.; Hans, S. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J. Intern. Med. 2020, 288, 335–344. [Google Scholar] [CrossRef]
- Sudre, C.H.; Murray, B.; Varsavsky, T.; Graham, M.S.; Penfold, R.S.; Bowyer, R.C.; Pujol, J.C.; Klaser, K.; Antonelli, M.; Canas, L.S.; et al. Attributes and predictors of Long-COVID. Nat. Med. 2020, 27, 626–631. [Google Scholar] [CrossRef]
- Tahir, F.; Bin Arif, T.; Majid, Z.; Ahmed, J.; Khalid, M. Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature. Cureus 2020, 12, e7868. [Google Scholar] [CrossRef]
- Sociedad Española de Médicos Generales y de Familia (SEMG), Colectivo de Pacientes Long COVID ACTS. Kit de Atención Básica al Paciente con Enfermedad de COVID-19 Persistente. 2020. Available online: https://www.coppa.es/gestor/uploads/noticias/documentos/Kit_de_atencio__n_al_paciente_con_COVID_persistente_SEMG.pdf (accessed on 12 July 2022).
- Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES), Ministerio de Sanidad. Información Científico-Técnica. Enfermedad por Coronavirus, COVID-19 Actualización, 15 de Enero. 2021. Available online: https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/ITCoronavirus/home.htm (accessed on 12 July 2022).
- Livanos, A.E.; Jha, D.; Cossarini, F.; Gonzalez-Reiche, A.S.; Tokuyama, M.; Aydillo, T.; Parigi, T.L.; Ladinsky, M.S.; Ramos, I.; Dunleavy, K.; et al. Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms. Gastroenterology 2021, 160, 2435–2450. [Google Scholar] [CrossRef] [PubMed]
- Mazza, M.G.; De Lorenzo, R.; Conte, C.; Poletti, S.; Vai, B.; Bollettini, I.; Melloni, E.M.T.; Furlan, R.; Ciceri, F.; Rovere-Querini, P.; et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav. Immun. 2020, 89, 594–600. [Google Scholar] [CrossRef] [PubMed]
- BAPEN. MUST, Malnutrition Universal Screening Tool. Available online: https://www.bapen.org.uk/pdfs/must/must_full.pdf (accessed on 12 July 2022).
- Parra-Rodríguez, L.; Szlejf, C.; García-González, A.I.; Malmstrom, T.K.; Cruz-Arenas, E.; Rosas-Carrasco, O. Cross-Cultural Adaptation and Validation of the Spanish-Language Version of the SARC-F to Assess Sarcopenia in Mexican Community-Dwelling Older Adults. J. Am. Med. Dir. Assoc. 2016, 17, 1142–1146. [Google Scholar] [CrossRef] [PubMed]
- Jette, A.M.; Davies, A.R.; Cleary, P.D.; Calkins, D.R.; Rubenstein, L.V.; Fink, A.; Kosecoff, J.; Young, R.T.; Brook, R.H.; Delbanco, T.L. The functional status questionnaire. J. Gen. Intern. Med. 1986, 1, 143–149. [Google Scholar] [CrossRef]
- Baecke, J.; Burema, J.; Frijters, J. The Questionnaire of Baecke et al. for Measurement of a Person’s Habitual Physical Activity. Am. J. Clin. Nutr. 2018, 36, 3–8. [Google Scholar]
- González-Blanc, C.; Umaran-Alfageme, O.; Cordero-Andrés, P.; Muñoz-Navarro, R.; Ruiz-Rodríguez, P.; Medrano, L.A. Ansiedad y Estrés. Ansiedad Estrés 2018, 24, 1–11. [Google Scholar]
- Grazziano, E.S.; Ferraz Bianchi, E.R. Impacto del estrés ocupacional y burnout en enfermeros. Enferm. Glob. 2010, 18, 1–20. [Google Scholar] [CrossRef] [Green Version]
- Del Pino Casado, R.; Martínez Riera, J.R. Estrategias para mejorar la visibilidad y accesibilidad de los cuidados enfermeros en atención primaria de salud. Rev. Adm. Sanit. Siglo XXI 2007, 5, 311–337. [Google Scholar]
- Martínez-Riera, J.R.; Gras-Nieto, E. Atención domiciliaria y COVID-19. Antes, durante y después del estado de alarma. Enferm. Clín. 2021, 31, 24–28. [Google Scholar] [CrossRef]
- Schapira, M. Impacto psicosocial de la pandemia por COVID-19 en adultos mayores con demencia y sus cuidadores. Rev. Argent. Salud Pública 2020, 12, e4. [Google Scholar]
- Munster, V.J.; Koopmans, M.; van Doremalen, N.; van Riel, D.; de Wit, E. A novel coronavirus emerging in China—Key questions for impact assessment. N. Engl. J. Med. 2020, 382, 692–694. [Google Scholar] [CrossRef] [PubMed]
- Lipson, J.G. Cultura y Cuidados de Enfermería. Index Enferm. 2000, 28, 19–25. [Google Scholar]
- Trilla, A. One world, one health: The novel coronavirus COVID-19 epidemic. Med. Clin. 2020, 154, 175–177. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cárdaba-García, R.M.; Durantez-Fernández, C.; Pérez, L.P.; Barba-Pérez, M.Á.; Olea, E. What Do We Know Today about Long COVID? Nursing Care for a New Clinical Syndrome. Int. J. Environ. Res. Public Health 2022, 19, 8642. https://doi.org/10.3390/ijerph19148642
Cárdaba-García RM, Durantez-Fernández C, Pérez LP, Barba-Pérez MÁ, Olea E. What Do We Know Today about Long COVID? Nursing Care for a New Clinical Syndrome. International Journal of Environmental Research and Public Health. 2022; 19(14):8642. https://doi.org/10.3390/ijerph19148642
Chicago/Turabian StyleCárdaba-García, Rosa M., Carlos Durantez-Fernández, Lucía Pérez Pérez, María Ángeles Barba-Pérez, and Elena Olea. 2022. "What Do We Know Today about Long COVID? Nursing Care for a New Clinical Syndrome" International Journal of Environmental Research and Public Health 19, no. 14: 8642. https://doi.org/10.3390/ijerph19148642
APA StyleCárdaba-García, R. M., Durantez-Fernández, C., Pérez, L. P., Barba-Pérez, M. Á., & Olea, E. (2022). What Do We Know Today about Long COVID? Nursing Care for a New Clinical Syndrome. International Journal of Environmental Research and Public Health, 19(14), 8642. https://doi.org/10.3390/ijerph19148642